AdaptHealth financials
$5.67+0.35%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q2 '26 Jun 30 | Q1 '26 Mar 31 | Q4 '25 Dec 31 | Q3 '25 Sep 30 | Q2 '25 Jun 30 | Q1 '25 Mar 31 | Q4 '24 Dec 31 | Q3 '24 Sep 30 | Q2 '24 Jun 30 | Q1 '24 Mar 31 | Q4 '23 Dec 31 | Q3 '23 Sep 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $740.3M | $819.8M | $846.3M | $820.3M | $657.1M | $777.9M | $856.6M | $805.9M | $806.0M | $792.5M | $858.2M | $804.0M |
| Gross profit | $104.2M | $111.5M | $172.2M | $161.9M | $135.8M | $120.4M | $192.2M | $162.1M | $169.4M | $157.5M | $304.4M | $110.5M |
| Gross margin | 14.1% | 13.6% | 20.3% | 19.7% | 20.7% | 15.5% | 22.4% | 20.1% | 21.0% | 19.9% | 35.5% | 13.7% |
| Operating income | -$144.1M | $5.5M | -$73.7M | $61.7M | $33.5M | $23.2M | $97.7M | $63.5M | $52.0M | $50.5M | -$217.8M | -$461.0M |
| Net income | -$133.9M | -$16.0M | -$102.8M | $24.5M | $14.7M | -$7.2M | $42.6M | $22.9M | $17.8M | -$2.1M | -$254.5M | -$454.1M |
| Net margin | −18.1% | −2.0% | −12.1% | 3.0% | 2.2% | −0.9% | 5.0% | 2.8% | 2.2% | −0.3% | −29.7% | −56.5% |
| Diluted EPS | $-0.99 | $-0.12 | $-0.78 | $0.16 | $0.10 | $-0.05 | $0.31 | $0.15 | $0.13 | $-0.02 | $-1.95 | $-3.43 |
| EBITDA | $120.5M | $112.0M | $151.8M | $159.4M | $125.8M | $117.5M | $188.2M | $154.2M | $147.5M | $152.2M | $101.1M | $149.0M |
| Operating cash flow | $145.3M | $93.7M | $183.2M | $161.1M | $162.0M | $95.5M | $150.4M | $144.4M | $198.0M | $49.0M | $155.3M | $98.8M |
| Free cash flow | -$20.9M | -$27.5M | $79.3M | $66.8M | $73.3M | -$58.0K | $73.1M | $84.8M | $116.7M | -$38.9M | $66.6M | $21.7M |
| Diluted shares | 136.1M | 135.8M | 131.5M | 137.2M | 137.1M | 134.8M | 136.7M | 136.5M | 136.0M | 132.9M | 130.5M | 135.0M |
Balance sheet
| Period end | Jun 30 | Mar 31 | Dec 31 | Sep 30 | Jun 30 | Mar 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $43.3M | $48.0M | $106.1M | $80.4M | $68.6M | $53.6M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total debt | $1.93B | $1.87B | $1.79B | $1.80B | $1.82B | $2.00B |
| Total assets | $4.34B | $4.42B | $4.32B | $4.38B | $4.35B | $4.44B |
| Total liabilities | $2.95B | $2.91B | $2.79B | $2.76B | $2.76B | $2.86B |
| Shareholders' equity | $1.39B | $1.51B | $1.53B | $1.62B | $1.59B | $1.57B |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology